These include Oxycodone, Oxycontin, and Fentanyl
Cambridge, MA, USA: 2017
This is why CJC-1295 no DAC is also known as tetrasubstituted GRF (1-29), modified GRF (1-29) or simply mod GRF (1-29) [10]
Injectable Dose: 0.1 to 0.2 mg three times weekly Topical Option: Apply serum to target areas twice daily Combined Approach: Injectable 3x weekly plus topical to specific areas Duration: 8 to 12 weeks, can extend longer due to favorable safety profile The timing of GHK-Cu introduction matters for maximum benefit
The anti-doping agency USADA has issued specific warnings about BPC-157, calling it an "experimental peptide" with insufficient safety data
(PubMed) Talebian A, Soltani B, Banafshe HR, Moosavi GA, Talebian M, Soltani S